Trademark: 79214833
Word
AUREGEN BIOTHERAPEUTICS
Status Date
Tuesday, July 24, 2018
Registration Number
5521659
Registration Date
Tuesday, July 24, 2018
Filing Date
Thursday, April 13, 2017
Published for Opposition
Tuesday, May 8, 2018
40 3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services
9 Laboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
5 Biological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
44 Medical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
42 Technical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment
AUREGEN BIO THERAPEUTICS
"BIOTHERAPEUTICS"
Jul 24, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 14, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 14, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 23, 2018
Final Decision Transaction Processed By Ib
Nov 6, 2018
Final Disposition Notice Sent To Ib
Nov 6, 2018
Final Disposition Processed
Oct 24, 2018
Final Disposition Notice Created, To Be Sent To Ib
Jul 24, 2018
Registered-Principal Register
Jun 19, 2018
Limitation From The Ib Examined, No Action Is Needed
Jun 15, 2018
Limitation Of Goods Received From Ib
May 8, 2018
Official Gazette Publication Confirmation E-Mailed
May 8, 2018
Published For Opposition
Apr 18, 2018
Notification Of Notice Of Publication E-Mailed
Mar 30, 2018
Approved For Pub - Principal Register
Mar 23, 2018
Limitation From The Ib Examined, No Action Is Needed
Mar 16, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 16, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 14, 2018
Teas/Email Correspondence Entered
Mar 14, 2018
Correspondence Received In Law Office
Mar 14, 2018
Teas Response To Office Action Received
Dec 22, 2017
Limitation Of Goods Received From Ib
Oct 7, 2017
Refusal Processed By Ib
Sep 16, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Sep 16, 2017
Refusal Processed By Mpu
Sep 13, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Sep 12, 2017
Non-Final Action Written
Sep 5, 2017
Application Filing Receipt Mailed
Aug 31, 2017
Assigned To Examiner
Aug 31, 2017
New Application Office Supplied Data Entered
Aug 25, 2017
Limitation From Original Application Entered
Aug 24, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
